COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 1015: Articles 10141-10150  | Next

Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations
Goldhaber-Fiebert, J. D., Prince, L., Chin, E. T., Leidner, D., Studdert, D. M., Salomon, J. A., Andrews, J. R.
10.1101/2022.01.21.22269664 — Posted: 2022-01-23
Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2)
PERALTA SANTOS, A., Pinto Leite, P., Casaca, P., Fernandes, E., Freire Rodrigues, E., Moreno, J., Ricoca, V., Gomes, J. P., Ferreira, R., Isidro, J., Pinto, M., Borges, V., Vieira, L., Duarte, S., Sousa, C., Menezes, L., Almeida, J. P., Ferreira, B., Matias, A., Pelorito, A., Freire, S., Grilo, T., Medeiro Borges, C., Moutinho, V., Kislaya, I., Rodrigues, A. P., Leite, A., Nunes, B.
10.1101/2022.01.20.22269406 — Posted: 2022-01-23 Discussion: Offsite
B.1.617.2 SARS-CoV-2 (Delta) variant is associated with increased risk of hospitalization and death compared with B.1.1.7 SARS-CoV-2 (Alpha) variant
Freire Rodrigues, E., Moreno, J., Pinto Leite, P., Nunes, B., Gomes, J. P., Ferreira, R., Isidro, J., Borges, V., Vieira, L., Duarte, S., Sousa, C., Almeida, J. P., Menezes, L., Vaz, D., Leite, A., PERALTA SANTOS, A.
10.1101/2022.01.21.22268602 — Posted: 2022-01-23
Severe outcomes in residents of Long Term Care Facilities following infection with SARS-CoV-2 Omicron variant (VIVALDI study)
Krutikov, M., Stirrup, O., Nacer-Laidi, H., Azmi, B., Fuller, C., Tut, G., Palmer, T., Shrotri, M., Irwin-Singer, A., Baynton, V., The COVID-19 Genomics UK (COG-UK) consortium, , Hayward, A., Moss, P., Copas, A., Shallcross, L.
10.1101/2022.01.21.22269605 — Posted: 2022-01-23
Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients
Blanco, I., Violan, C., Suner, C., Garcia-Prieto, J., Argerich, M. J., Rodriguez-Illana, M., Moreno, N., Cardona, P.-J., Blanco, A., Toran-Montserrat, P., Clotet, B., Bonet, J. M., Prat, N.
10.1101/2022.01.20.22269539 — Posted: 2022-01-23
Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis
Lee, T. C., Murthy, S., Del Corpo, O. C., Senecal, J., Butler-Laporte, G., Sohani, Z. N., Brophy, J. M., McDonald, E. G.
10.1101/2022.01.22.22269545 — Posted: 2022-01-23
ESCPE-1 Mediates Retrograde Endosomal Sorting of the SARS-CoV-2 Host Factor Neuropilin-1
Simonetti, B., Daly, J. L., Simon-Gracia, L., Klein, K., Weeratunga, S., Anton-Plagaro, C., Tobi, A., Hodgson, L., Lewis, P., Heesom, K. J., Shoemark, D. K., Davidson, A. D., Collins, B. M., Teesalu, T., Yamauchi, Y., Cullen, P. J.
10.1101/2022.01.20.477115 — Posted: 2022-01-22
Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine
Xia, H., Zou, J., Kurhade, C., Cai, H., Yang, Q., Cutler, M., Cooper, D., Muik, A., Jansen, K. U., Xie, X., Swanson, K. A., Shi, P.-Y.
10.1101/2022.01.21.476344 — Posted: 2022-01-22
Broadly-recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
Becerra-Artiles, A., Calvo-Calle, J. M., Co, M., Nanaware, P., Cruz, J., Weaver, G. C., Lu, L., Forcini, C., Finberg, R. W., Moormann, A., Stern, L. J.
10.1101/2022.01.20.477107 — Posted: 2022-01-22
In Silico Analysis Of The Effects Of Omicron Spike Amino Acid Changes On The Interactions With Human ACE2 Receptor And Structurally Characterized Complexes With Human Antibodies
D'Arminio, N., Giordano, D., Scafuri, B., Biancaniello, C., Petrillo, M., Facchiano, A., Marabotti, A.
10.1101/2022.01.20.477105 — Posted: 2022-01-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).